Best-Selling Body Building Peptides Cjc-1295 with or Without Dac

Best-selling Body Building Peptides CJC-1295 With or Without DAC

1. CJC-1295 Peptides (863288-34-0) information 

CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a releasing hormone (GHRH) analog. 

One of the advantages of CJC-1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation. 

Due to the extremely long half life of CJC-1295 it is plausible for researchers to use this peptide once per week with outstanding results. Various experiments have been conducted to test the effectiveness of CJC-1295 in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased concentrations 1.5-3 fold for 9-11 days after a single injection! Not only that but they proved the mean half life to be 5.8-8.1 days and after multiple doses showed mean levels remained above baseline for up to 28 days following! No serious adverse reactions were reported in any group.

2. CJC-1295 Peptides (863288-34-0) detail 

Product Name: CJC-1295 
 
Cas No. 863288-34-0 
Molecular Formula: C165H271N47O46 
Molecular Weight : 3649.30 
Purity (HPLC): 98.0% 
Appearance: White powder 
Single Impurity(HPLC) :1.0% 
Amino Acid Composition: 10% of theoretical 
Peptide Content(N%): 80%(by %N) 
Water Content(Karl Fischer): 6.0% 
Acetate Content(HPIC): 15.0% 
Mass Balance: 95.0~105.0% 
Package: CJC-1295 with DAC 2mg/vial 10vials/kit 1g/bag 
CJC-1295 without DAC 2mg/vial 10vials/kit 1g/bag 

Best-selling Body Building Peptides CJC-1295 With or Without DAC

1. CJC-1295 Peptides (863288-34-0) information 

CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a releasing hormone (GHRH) analog. 

One of the advantages of CJC-1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation. 

Due to the extremely long half life of CJC-1295 it is plausible for researchers to use this peptide once per week with outstanding results. Various experiments have been conducted to test the effectiveness of CJC-1295 in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased concentrations 1.5-3 fold for 9-11 days after a single injection! Not only that but they proved the mean half life to be 5.8-8.1 days and after multiple doses showed mean levels remained above baseline for up to 28 days following! No serious adverse reactions were reported in any group.

2. CJC-1295 Peptides (863288-34-0) detail 

Product Name: CJC-1295 
 
Cas No. 863288-34-0 
Molecular Formula: C165H271N47O46 
Molecular Weight : 3649.30 
Purity (HPLC): 98.0% 
Appearance: White powder 
Single Impurity(HPLC) :1.0% 
Amino Acid Composition: 10% of theoretical 
Peptide Content(N%): 80%(by %N) 
Water Content(Karl Fischer): 6.0% 
Acetate Content(HPIC): 15.0% 
Mass Balance: 95.0~105.0% 
Package: CJC-1295 with DAC 2mg/vial 10vials/kit 1g/bag 
CJC-1295 without DAC 2mg/vial 10vials/kit 1g/bag